Generally, the idea of targeting PRDX1 in breast cancer has been proposed previously, and that notion originates from the observation that PRDX1 can inhibit H2O2-induced cell death in mammary carcinoma cells [42]. This evidence concerns the gene PRDX1 and breast carcinoma.